未登录 Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications Carrillo-Reixach, Juan; Torrens, Laura; Simon-Coma, Marina; Royo, Laura; Domingo-Sabat, Montserrat; Abril-Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Nuria; Cairo, Stefano; Villanueva, Alberto; Kappler, Roland; Garrido, Marta; Guerra, Laura; Sabado, Constantino; Guillen, Gabriela; Mallo, Mar; Pineyro, David; Vazquez-Vitali, Maria; Kuchuk, Olga; Elena Mateos, Maria; Ramirez, Gema; Lopez Santamaria, Manuel; Mozo, Yasmina; Soriano, Aroa; Grotzer, Michael; Branchereau, Sophie; Garcia de Andoin, Nagore; Lopez-Ibor, Blanca; Lopez-Almaraz, Ricardo; Antonio Salinas, Jose; Torres, Barbara; Hernandez, Francisco; Javier Uriz, Jose; Fabre, Monique; Blanco, Julia; Paris, Claudia; Bajciova, Viera; Laureys, Genevieve; Masnou, Helena; Clos, Ariadna; Belendez, Cristina; Guettier, Catherine; Sumoy, Lauro; Planas, Ramon; Jorda, Mireia; Nonell, Lara; Czauderna, Piotr; Morland, Bruce; Sia, Daniela; Losic, Bojan; Buendia, Marie Annick; Rosa Sarrias, Maria; Llovet, Josep M.; Armengol, Carolina 分享 收藏
High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study 欧洲成人不明肝病患者肝纤维化患病率高: 一项基于人群的研究 Caballeria, Llorenc; Pera, Guillem; Arteaga, Ingrid; Rodriguez, Lluis; Aluma, Alba; Morillas, Rosa Ma; de la Ossa, Napoleon; Diaz, Alba; Exposito, Carmen; Miranda, Dolores; Sanchez, Carmen; Prats, Rosa M. A.; Urquizu, Marta; Salgado, Angels; Alemany, Magda; Martinez, Alba; Majeed, Irfan; Fabrellas, Nuria; Graupera, Isabel; Planas, Ramon; Ojanguren, Isabel; Serra, Miquel; Toran, Pere; Caballeria, Juan; Gines, Pere 分享 收藏
CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78) Aran, Gemma; Sanjurjo, Lucia; Barcena, Cristina; Simon-Coma, Marina; Tellez, Erica; Vazquez-Vitali, Maria; Garrido, Marta; Guerra, Laura; Diaz, Esther; Ojanguren, Isabel; Elortza, Felix; Planas, Ramon; Sala, Margarita; Armengol, Carolina; Sarrias, Maria-Rosa 分享 收藏
HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis Morales, Betty P.; Planas, Ramon; Bartoli, Ramon; Morillas, Rosa M.; Sala, Margarita; Casas, Irma; Armengol, Carolina; Masnou, Helena 分享 收藏
分享 收藏
Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factors Morales, Betty P.; Planas, Ramon; Bartoli, Ramon; Morillas, Rosa M.; Sala, Margarita; Cabre, Eduard; Casas, Irma; Masnou, Helena 分享 收藏
Simeprevir and daclatasvir for 12 or 24weeks in treatment-naive patients with hepatitis C virus genotype 1b and advanced liver disease Hezode, Christophe; Almasio, Piero L.; Bourgeois, Stefan; Buggisch, Peter; Brown, Ashley; Diago, Moises; Horsmans, Yves; Serfaty, Lawrence; Szalay, Ferenc; Gaeta, Giovanni B.; Planas, Ramon; Schlag, Michael; Lonjon-Domanec, Isabelle; Omoruyi, Edmund; DeMasi, Ralph; Zeuzem, Stefan 分享 收藏
Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study Puigvehi, M.; Londono, M-C; Morillas, R. M.; Miquel, M.; Gallego, A.; Lens, S.; Marino, Z.; Vergara, M.; Lorente, S.; Torras, X.; Planas, R.; Sola, R.; Carrion, J. A. 分享 收藏
Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO) Buti, M.; Calleja, J. L.; Lens, S.; Diago, M.; Ortega, E.; Crespo, J.; Planas, R.; Romero-Gomez, M.; Rodriguez, F. G.; Pascasio, J. M.; Fevery, B.; Kurland, D.; Corbett, C.; Kalmeijer, R.; Jessner, W. 分享 收藏
EFFICACY AND TOLERABILITY OF SIMEPREVIR AND DACLATASVIR FOR 12 OR 24 WEEKS IN HCV GENOTYPE 1B-INFECTED TREATMENT-NAIVE PATIENTS WITH ADVANCED FIBROSIS OR COMPENSATED CIRRHOSIS Hezode, C.; Almasio, P.; Bourgeois, S.; Buggisch, P.; Brown, A.; Diago, M.; Horsmans, Y.; Serfaty, L.; Szalay, F.; Gaeta, G. B.; Planas, R.; Schlag, M.; Lonjon-Domanec, I.; Gilles, L.; DeMasi, R.; Zeuzem, S. 分享 收藏
SIMEPREVIR PLUS SOFOSBUVIR FOR HEPATITIS C VIRUS GENOTYPE 4 INFECTION: A PHASE 3, OPEN-LABEL STUDY Buti, M.; Calleja, J. L.; Forns, X.; Diago, M.; Ortega, E.; Crespo, J.; Planas, R.; Fevery, B.; Kurland, D.; Buelens, A.; Corbett, C.; Kalmeijer, R.; Jessner, W. 分享 收藏
COMPREHENSIVE PROTEOMIC STUDY OF HEPATOBLASTOMA: IDENTIFICATION OF A PROGNOSTIC SIGNATURE AND DEREGULATED PATHWAYS Simon, M.; Azkargorta, M.; Guerra, L.; Nonell, L.; Lopez-Santamaria, M.; Garrido, M.; Mateos, M. E.; Belendez, C.; Plaza, D.; Hernandez, F.; Mendiola, M.; Ojanguren, I.; Childs, M.; Czauderna, P.; Maibach, R.; Morland, B.; Buendia, M. A.; Elortza, F.; Planas, R.; Sarrias, M. -R.; Sala, M.; Armengol, C. 分享 收藏
PLATELET COUNT AND LIVER STIFFNESS MEASUREMENT TO EXCLUDE HIGH-RISK GASTROESOPHAGEAL VARICES IN PATIENTS WITH HCV-CIRRHOSIS. A MULTICENTRIC STUDY Puigvehi, M.; Londono, M. -C.; Morillas, R. M.; Miquel, M.; Gallego, A.; Lens, S.; Marino, Z.; Vergara, M.; Lorente, S.; Torras, X.; Planas, R.; Sola, R.; Carrion, J. A. 分享 收藏
COST-EFFECTIVENESS ANALYSIS OF TRIPLE THERAPY WITH PEGINTERFERON, RIBAVIRIN, AND BOCEPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 WITH SEVERE FIBROSIS UNDER REAL-LIFE CONDITIONS Ruiz-Antoran, B.; Pascasio, J. M.; Gea, F.; Barcena, R.; Larrubia, J.; Perez Alvarez, R.; Sousa, J.; Romero-Gomez, Manuel; Sola, R.; de la Revilla, J.; Crespo, J.; Navarro, J.; Arenas, J.; Delgado, M.; Fernandez Rodriguez, C.; Planas, R.; Buti, M.; Forns, X.; Calleja, J. L. 分享 收藏
分享 收藏
分享 收藏
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis Calleja, Jose L.; Pascasio, Juan M.; Ruiz-Antoran, Belen; Gea, Francisco; Barcena, Rafael; Larrubia, Juan R.; Perez-Alvarez, Ramon; Sousa, Jose M.; Romero-Gomez, Manuel; Sola, Ricard; de la Revilla, Juan; Crespo, Javier; Navarro, Jose M.; Arenas, Juan I.; Delgado, Manuel; Fernandez-Rodriguez, Conrado M.; Planas, Ramon; Buti, Maria; Forns, Xavier 分享 收藏
ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV Ferenci, Peter; Bernstein, David; Lalezari, Jacob; Cohen, Daniel; Luo, Yan; Cooper, Curtis; Tam, Edward; Marinho, Rui T.; Tsai, Naoky; Nyberg, Anders; Box, Terry D.; Younes, Ziad; Enayati, Pedram; Green, Sinikka; Baruch, Yaacov; Bhandari, Bal Raj; Caruntu, Florin Alexandru; Sepe, Thomas; Chulanov, Vladimir; Janczewska, Ewa; Rizzardini, Giuliano; Gervain, Judit; Planas, Ramon; Moreno, Christophe; Hassanein, Tarek; Xie, Wangang; King, Martin; Podsadecki, Thomas; Reddy, K. Rajender 分享 收藏
UTILITY OF SERUM MARKERS AND TRANSIENT ELASTOGRAPHY TO IDENTIFY SERIOUS ADVERSE EFFECTS DURING ANTIVIRAL THERAPY IN HCV INFECTED CIRRHOTIC PATIENTS. A MULTICENTER STUDY Puigvehi, M.; Londono, M. C.; Morillas, R. M.; Miquel, M.; Gallego, A.; Lens, S.; Baiges, A.; Vergara, M.; Torras, X.; Planas, R.; Sola, R.; Carrion, A. 分享 收藏
PEARL-III: 12 WEEKS OF ABT-450/R/267+ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN Ferenci, P.; Nyberg, A.; Enayati, P.; Bernstein, D.; Baruch, Y.; Caruntu, F. A.; Chulanov, V.; Janczewska, E.; Younes, Z.; Marinho, R. T.; Rizzardini, G.; Gervain, J.; Planas, R.; Moreno, C.; Xie, W.; Cohen, D.; King, M.; Podsadecki, T.; Reddy, K. R. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
